Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Quartette side effects?
Guselkumab loss of exclusitivy?
Dabrafenib btd date 2023?
Atorvastatin side effects heart palpitations?
How does iron rich food intake impact lipitor's efficacy?

Generic for carbamazepine?

See the DrugPatentWatch profile for carbamazepine

Carbamazepine is available as a generic medication. The active ingredient, carbamazepine, is used to treat epilepsy, nerve pain, and bipolar disorder [1].

When does carbamazepine patent expire?

The original patents for carbamazepine have long expired. Its development dates back to the 1950s and 1960s [2]. However, newer formulations or delivery systems of carbamazepine may have separate patent protections. Information on specific patents and their expiry dates can be found through resources like DrugPatentWatch.com [3].

What is the difference between carbamazepine and brand-name versions?

The primary difference between generic carbamazepine and its brand-name counterparts, such as Tegretol, is the inactive ingredients. Generic medications must contain the same active ingredient in the same dosage and strength as the brand-name drug. The inactive ingredients, like fillers or dyes, may differ. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA), ensure that generic drugs are bioequivalent to their brand-name versions, meaning they work in the body in the same way [1].

How much does generic carbamazepine cost?

The cost of generic carbamazepine is typically significantly lower than its brand-name equivalent. Prices can vary depending on the pharmacy, insurance coverage, and dosage form. Purchasing generic medications is a common way to reduce healthcare expenses [1].

Who manufactures generic carbamazepine?

Numerous pharmaceutical companies manufacture generic versions of carbamazepine. These manufacturers must meet strict quality and manufacturing standards set by regulatory agencies. Companies like Teva Pharmaceuticals, Mylan (now Viatris), and Aurobindo Pharma are among those that produce generic carbamazepine [4].

What are the common uses for carbamazepine?

Carbamazepine is prescribed to manage seizure disorders, including epilepsy. It is also used to treat trigeminal neuralgia, a type of facial nerve pain, and to manage mood swings associated with bipolar disorder [1].

What are the side effects of carbamazepine?

Common side effects of carbamazepine can include dizziness, drowsiness, unsteadiness, nausea, and vomiting. More serious side effects, though less common, can include rash, fever, sore throat, mouth sores, easy bruising or bleeding, and severe skin reactions. Patients should report any concerning side effects to their healthcare provider [1].

Are there alternatives to carbamazepine?

Yes, there are alternative medications for epilepsy, nerve pain, and bipolar disorder. For epilepsy, other anticonvulsants are available. For trigeminal neuralgia, other pain medications might be considered. For bipolar disorder, mood stabilizers and antipsychotic medications are often used. The choice of an alternative depends on the specific condition, individual patient needs, and response to treatment [1].

Sources:
[1] National Institutes of Health. (n.d.). Carbamazepine. MedlinePlus. https://medlineplus.gov/druginfo/meds/a682071.html
[2] Harden, C. L., & Kanner, A. M. (2012). Carbamazepine: clinical pharmacology and therapeutic use. Drug Safety, 35(5), 355-371.
[3] DrugPatentWatch.com. (n.d.). Carbamazepine Patents. https://drugpatentwatch.com/search?drug=Carbamazepine
[4] U.S. Food and Drug Administration. (n.d.). Approved Drug Products. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm



Other Questions About Carbamazepine :

Who makes carbamazepine? Carbamazepine for trigeminal neuralgia? Carbamazepine 100mg price? How much is carbamazepine? Carbamazepine brand name? Which drug stops rhythmic muscular contraction better—carbamazepine or lacosamide? Carbamazepine cheap?

AI-Drug Label Prescribing Information Alignment Report

92
92%
Grade A

Excellent

Mostly Aligned

Patient Risk: Low

Summary

The provided evaluation/claims about HLA-B*1502 and SJS/TEN risk are supported by the supplied FDA label excerpts (Section 5), including the strong association, pre-treatment testing recommendation, and avoidance guidance for HLA-B*1502–positive patients unless benefits clearly outweigh risks.

Category Scores

Contraindications
90
Excellent
Warnings
100
Excellent

Accurate Statements

Strong association between carbamazepine-related SJS/TEN risk and the HLA-B*1502 allele.
FDA label (WARNINGS, Section 5: “Serious Dermatologic Reactions and HLA-B*1502 Allele” and “SJS/TEN and HLA-B*1502 Allele”): studies in Chinese ancestry show a strong association between developing SJS/TEN with carbamazepine and presence of HLA-B*1502.
HLA-B*1502 testing should be performed prior to initiating carbamazepine therapy in genetically at-risk patients/ancestries where HLA-B*1502 may be present.
FDA label (WARNINGS, Section 5: “SJS/TEN and HLA-B*1502 Allele” and PRECAUTIONS/Laboratory Tests): “Prior to initiating carbamazepine therapy, testing for HLA-B*1502 should be performed…”; “high-resolution ‘HLA-B*1502 typing’ is recommended.”
Carbamazepine should not be used in patients testing positive for HLA-B*1502 unless the benefits clearly outweigh the risks.
FDA label (WARNINGS, Section 5: “Serious Dermatologic Reactions and HLA-B*1502 Allele” and “SJS/TEN and HLA-B*1502 Allele”): “Patients testing positive for the allele should not be treated… unless the benefit clearly outweighs the risk.” / “Carbamazepine should not be used… unless the benefits clearly outweigh the risks.”

Unsupported Statements

Contradictions

Important Omissions

The evaluation does not explicitly restate the label’s discontinuation/resumption guidance at the first sign of rash or to not resume if signs/symptoms suggest SJS/TEN.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
The core pharmacogenomic risk-mitigation message (HLA-B*1502 association with SJS/TEN, recommended testing in at-risk ancestries, and avoidance in positives unless benefit outweighs risk) is consistent with the supplied FDA labeling excerpt.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue
Omission of label discontinuation and non-resumption guidance for suspected SJS/TEN at the first sign of rash.

Suggested Improvement
Add that carbamazepine should be discontinued at the first sign of a rash (unless clearly not drug-related) and should not be resumed if signs/symptoms suggest SJS/TEN, with alternative therapy considered.

Drug Brand Mention Assessment

Branding Score
44
Visibility
50
Mentioned
Ranking
#1
Sentiment
55
Recommendation Status
mentioned only
Brand Perception
Best Known For

treated epilepsy, nerve pain, and bipolar disorder

Core Claims
  • Carbamazepine is available as a generic medication.
  • The active ingredient, carbamazepine, is used to treat epilepsy, nerve pain, and bipolar disorder.
  • Generic carbamazepine differs mainly in inactive ingredients versus brand-name counterparts like Tegretol.
  • Cost of generic carbamazepine is typically significantly lower than its brand-name equivalent.
  • Numerous pharmaceutical companies manufacture generic carbamazepine.
Differentiators
  • Generic medications must contain the same active ingredient in the same dosage and strength as the brand-name drug.
  • Inactive ingredients (fillers or dyes) may differ.
  • Regulatory bodies ensure generic drugs are bioequivalent to their brand-name versions.
Pricing Perception: Mid Range